These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16024120)

  • 21. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?
    Sanguineti G; Cavey ML; Endres EJ; Brandon GG; Bayouth JE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):151-60. PubMed ID: 16198066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling the variation in rectal dose due to inter-fraction rectal wall deformation in external beam prostate treatments.
    Booth J; Zavgorodni S
    Phys Med Biol; 2005 Nov; 50(21):5055-74. PubMed ID: 16237241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer.
    Di Muzio N; Fiorino C; Cozzarini C; Alongi F; Broggi S; Mangili P; Guazzoni G; Valdagni R; Calandrino R; Fazio F
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):392-8. PubMed ID: 19056184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?
    Sanguineti G; Cavey ML; Endres EJ; Franzone P; Barra S; Parker BC; Marcenaro M; Colman M; Agostinelli S; Foppiano F; Vitale V
    Strahlenther Onkol; 2006 Sep; 182(9):543-9. PubMed ID: 16944377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
    Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer.
    Krayenbuehl J; Davis JB; Ciernik IF
    Radiother Oncol; 2006 Nov; 81(2):151-7. PubMed ID: 17055095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between manual and automatic segment generation in step-and-shoot IMRT of prostate cancer.
    Bos LJ; Schwarz M; Bär W; Alber M; Mijnheer BJ; Lebesque JV; Damen EM
    Med Phys; 2004 Jan; 31(1):122-30. PubMed ID: 14761028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of patient setup errors on simultaneously integrated boost head and neck IMRT treatment plans.
    Siebers JV; Keall PJ; Wu Q; Williamson JF; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):422-33. PubMed ID: 16168835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric consequences of intrafraction prostate motion.
    Li HS; Chetty IJ; Enke CA; Foster RD; Willoughby TR; Kupellian PA; Solberg TD
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):801-12. PubMed ID: 18234439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of dose compensation in image-guided radiotherapy of prostate cancer.
    Wu Q; Liang J; Yan D
    Phys Med Biol; 2006 Mar; 51(6):1405-19. PubMed ID: 16510952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integral radiation dose to normal structures with conformal external beam radiation.
    Aoyama H; Westerly DC; Mackie TR; Olivera GH; Bentzen SM; Patel RR; Jaradat H; Tome WA; Ritter MA; Mehta MP
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):962-7. PubMed ID: 16458781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internal fiducial markers can assist dose escalation in treatment of prostate cancer: result of organ motion simulations.
    Zhang M; Moiseenko V; Liu M; Craig T
    Phys Med Biol; 2006 Jan; 51(2):269-85. PubMed ID: 16394338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric effects of patient rotational setup errors on prostate IMRT treatments.
    Fu W; Yang Y; Li X; Heron DE; Huq MS; Yue NJ
    Phys Med Biol; 2006 Oct; 51(20):5321-31. PubMed ID: 17019041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.